Ensign Peak Advisors, Inc - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ensign Peak Advisors, Inc ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$424,390
-54.7%
37,0000.0%0.00%
-50.0%
Q2 2023$936,470
-21.4%
37,0000.0%0.00%
-33.3%
Q1 2023$1,191,770
+74.5%
37,0000.0%0.00%
+50.0%
Q4 2022$683,020
+16.0%
37,000
+69.7%
0.00%
+100.0%
Q3 2022$589,000
+95.7%
21,8000.0%0.00%0.0%
Q2 2022$301,000
-29.2%
21,8000.0%0.00%0.0%
Q1 2022$425,000
+96.8%
21,800
+64.8%
0.00%
Q4 2021$216,00013,2300.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders